| Christopher Orelup, MD | |
|
2800 Main St, St. Vincent's Medical Center, Bridgeport, CT 06606-4201 | |
| (203) 576-6000 | |
| Not Available |
| Full Name | Christopher Orelup |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 2800 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417094210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 043079 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
The conclusion by the Food and Drug Administration's (FDA) that the widely used chemical bisphenol-A, or BPA, is safe has been slammed by a panel of experts.
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
› Verified 5 days ago
| Entity Name | Norwalk Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427041581 PECOS PAC ID: 3375436660 Enrollment ID: O20040202000988 |
News Archive
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
The conclusion by the Food and Drug Administration's (FDA) that the widely used chemical bisphenol-A, or BPA, is safe has been slammed by a panel of experts.
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
› Verified 5 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
The conclusion by the Food and Drug Administration's (FDA) that the widely used chemical bisphenol-A, or BPA, is safe has been slammed by a panel of experts.
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
› Verified 5 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
The conclusion by the Food and Drug Administration's (FDA) that the widely used chemical bisphenol-A, or BPA, is safe has been slammed by a panel of experts.
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Orelup, MD 2800 Main St, St. Vincent's Medical Center, Bridgeport, CT 06606-4201 Ph: (203) 576-6000 | Christopher Orelup, MD 2800 Main St, St. Vincent's Medical Center, Bridgeport, CT 06606-4201 Ph: (203) 576-6000 |
News Archive
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.
The conclusion by the Food and Drug Administration's (FDA) that the widely used chemical bisphenol-A, or BPA, is safe has been slammed by a panel of experts.
IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.
Unigene Laboratories, Inc. (http://www.unigene.com) today announced that it has entered into an amended and restated financing agreement for $33 million three-year convertible senior secured term notes.
› Verified 5 days ago
Dr. Tanya Dhiren Shah, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 | |
Dr. Kevin J Sprague Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Emergency Department, Bridgeport, CT 06606 Phone: 203-576-5604 | |
Sally Syaunan Chao, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2800 Main St, St. Vincent Medical Center, Bridgeport, CT 06606 Phone: 203-576-5177 | |
Kimberly Anne Reade, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Emergency Department, Bridgeport, CT 06606 Phone: 203-576-5604 | |
Dr. Jonathan Maisel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-4490 | |
Dr. Roland Martin Jermyn Iii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3256 Fax: 203-384-4037 | |
Samantha Dane, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, St. Vincent Medical Center, Bridgeport, CT 06606 Phone: 203-576-5177 |